十一月 2025
- Home
- New England Biolabs, Inc.
十一月 2025的New England Biolabs, Inc.市场份额分析
neb is a leader in the discovery and development of molecular biology reagents. restriction enzymes, polymerases, competent cells,sample prep for ngs, and more.
New England Biolabs, Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- neb.com
New England Biolabs, Inc.收入截至 十一月 2025为 100M - 200M
New England Biolabs, Inc.主要域名产生的收入
3 年中New England Biolabs, Inc.主要域名的收入
New England Biolabs, Inc.主要域名的收入
New England Biolabs, Inc.热门域名的总访问量
了解New England Biolabs, Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
New England Biolabs, Inc.热门域名的平均访问时长
分析New England Biolabs, Inc.参与度指标。
过去 3 个月的平均访问时长
子公司明细
New England Biolabs, Inc.热门域名的平均页面浏览量
了解New England Biolabs, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
New England Biolabs, Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻New England Biolabs, Inc. launched NEBNext Flu A Integrated Indexing Primer Module on Nov 14th '25.New England Biolabs (NEB(R) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), designed to streamline and scale the sequencing of Influenza A virus from a range of species and sample types using Oxford Nanopore Technologies (ONT) platforms.
十一月 14, 2025阅读更多
新闻New England Biolabs, Inc. attended event Association for Molecular Pathology (AMP) Annual Meeting & Expo on Nov 11th '25.IPSWICH, Mass., Nov. 10, 2025 /PRNewswire/ - New England Biolabs (NEB(R), a global leader in enzyme technologies and molecular biology solutions, will highlight its latest advances in molecular diagnostics and infectious disease surveillance at the Association for Molecular Pathology (AMP) Annual Meeting & Expo, taking place November 11 - 15, 2025, in Boston, MA.
十一月 10, 2025阅读更多
新闻Hunts Office partners with New England Biolabs, Inc..Hunts Office partnered with NEB to create a workspace that reflects the company's commitment to innovation and sustainability.
九月 16, 2025阅读更多
查看 New England Biolabs, Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。